Joseph Lockinger

Cooley advised Brigit, a financial health technology company, on its definitive agreement to be acquired by Upbound Group (Nasdaq: UPBD), a technology- and data-driven leader in accessible and inclusive financial products that address the evolving needs and aspirations of underserved consumers, for total consideration of up to $460 million.

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Cooley advised Biote, a medical practice-building business within the hormone optimization space, on its definitive business combination agreement with special purpose acquisition company (SPAC) Haymaker Acquisition Corp III. Lawyers Michal Berkner and Jarrett Burks led the Cooley team advising Biote.

Cooley advised DailyPay, an on-demand pay solution for enterprises, on its $175 million Series D financing round, as well as its $325 million of credit capital from various sources. Sacha Ross and Ariel Rom led the Cooley team advising DailyPay on the investments, which propelled the fintech company to unicorn status.

Cooley advised White Ops, a leader in bot mitigation, bot prevention and ad fraud prevention, on its sale to Goldman Sachs Merchant Banking Division, ClearSky Security, and Nightdragon. Lawyers Izzy Lubarsky, Eric Dixon, Alex Fagella, Tanisha James, Stephanie Gentile, Joshua Friedman and Joseph Lockinger led the Cooley team.